Gene · 994
Papers2,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,079
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tamoxifen resistance-related ceRNA network for breast cancer. | Front Cell Dev Biol | 2022 | 36506097 | PubTator, text mining | PubMed |
| ATR Inhibitors in Platinum-Resistant Ovarian Cancer. | Cancers (Basel) | 2022 | 36497387 | PubTator, text mining | PubMed |
| Long Noncoding RNA and mRNA m6A Modification Analyses of Periodontal Ligament Stem Cells from the Periodontitis Microenvironment Exposed to Static Mechanical Strain. | Stem Cells Int | 2022 | 36483682 | PubTator, text mining | PubMed |
| MiR-214-3p targets Ras-related protein 14 (RAB14) to inhibit cellular migration and invasion in esophageal Cancer cells. | BMC Cancer | 2022 | 36471277 | PubTator, text mining | PubMed |
| Corrigendum: Dual-specificity phosphatase CDC25B was inhibited by natural product HB-21 through covalently binding to the active site. | Front Chem | 2022 | 36465865 | PubTator, text mining | PubMed |
| Lactate-dependent chaperone-mediated autophagy induces oscillatory HIF-1α activity promoting proliferation of hypoxic cells. | Cell Syst | 2022 | 36462504 | PubTator, text mining | PubMed |
| Genetics of Oocyte Maturation Defects and Early Embryo Development Arrest. | Genes (Basel) | 2022 | 36360157 | PubTator, text mining | PubMed |
| Autoantibodies - enemies, and/or potential allies? | Front Immunol | 2022 | 36341384 | PubTator, text mining | PubMed |
| Perfluoroalkyl substances (PFASs) decrease the expression of recombination-activating genes (RAG1 and RAG2) in human B lymphoma Namalwa cells. | Arch Toxicol | 2022 | 36326898 | PubTator, text mining | PubMed |
| Circular RNA hsa-circ-0005238 enhances trophoblast migration, invasion and suppresses apoptosis via the miR-370-3p/CDC25B axis. | Front Med (Lausanne) | 2022 | 36314002 | PubTator, text mining | PubMed |
| Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer. | Front Oncol | 2022 | 36300085 | PubTator, text mining | PubMed |
| Advances in Fungal Phenaloenones-Natural Metabolites with Great Promise: Biosynthesis, Bioactivities, and an In Silico Evaluation of Their Potential as Human Glucose Transporter 1 Inhibitors. | Molecules | 2022 | 36296388 | PubTator, text mining | PubMed |
| Molecular Pathways Related to Sulforaphane as Adjuvant Treatment: A Nanomedicine Perspective in Breast Cancer. | Medicina (Kaunas) | 2022 | 36295538 | PubTator, text mining | PubMed |
| Secondary Metabolites from Coral-Associated Fungi: Source, Chemistry and Bioactivities. | J Fungi (Basel) | 2022 | 36294608 | PubTator, text mining | PubMed |
| Non-Coding RNAs Are Implicit in Chronic Myeloid Leukemia Therapy Resistance. | Int J Mol Sci | 2022 | 36293127 | PubTator, text mining | PubMed |
| The Diagnostic and Therapeutic Role of Circular RNA HIPK3 in Human Diseases. | Diagnostics (Basel) | 2022 | 36292157 | PubTator, text mining | PubMed |
| Understanding Mechanisms of RKIP Regulation to Improve the Development of New Diagnostic Tools. | Cancers (Basel) | 2022 | 36291854 | PubTator, text mining | PubMed |
| Mining the Immunopeptidome for Antigenic Peptides in Cancer. | Cancers (Basel) | 2022 | 36291752 | PubTator, text mining | PubMed |
| Exploiting the Molecular Basis of Oesophageal Cancer for Targeted Therapies and Biomarkers for Drug Response: Guiding Clinical Decision-Making. | Biomedicines | 2022 | 36289620 | PubTator, text mining | PubMed |
| Revealing β-TrCP activity dynamics in live cells with a genetically encoded biosensor. | Nat Commun | 2022 | 36289220 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/994/papers?page=12